signalling transduction
In cases of SWD, reversing wound hypoxia through Continuous Topical Oxygen Therapy (cTOT) can significantly support tissue repair and reduce the risk of infection and biofilm formation.¹ As such, cTOT represents a meaningful advancement in supporting healing when dehiscence risk factors are present.¹ Scroll through the case studies below to see how NATROX® O₂ has been used successfully in real-world surgical wound dehiscence healing scenarios.
Surgical wound dehiscence (SWD)—the separation of the margins of a closed surgical incision—typically occurs within 5 to 8 days postoperatively, secondary to infection, and can expose patients to serious complications and delayed healing.¹﹐²
Oxygen plays a vital role in the wound healing cascade, contributing to oxidative bacterial killing, cellular signaling, collagen synthesis, and angiogenesis.¹
References:
Sandy-Hodgetts K, Leung E, Andrews E, et al. Surgical wound dehiscence (SWD): International consensus statement on assessment, diagnosis and management. London: Wounds International; 2023